DIFFERENTIAL-EFFECTS OF THE ADMINISTRATION OF HUMAN CHORIONIC-GONADOTROPIN TO POSTNATAL RATS

被引:17
|
作者
GAYTAN, F [1 ]
PINILLA, L [1 ]
ROMERO, JL [1 ]
AGUILAR, E [1 ]
机构
[1] UNIV CORDOBA,SCH MED,DEPT PHYSIOL,E-14071 CORDOBA,SPAIN
关键词
D O I
10.1677/joe.0.1420527
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neonatal and prepubertal male rats were treated with human chorionic gonadotropin (hCG, 5 IU/g body weight per day) on days 2-4 or 20-22. Depending on the date of treatment, different groups of rats were sacrificed at 5, 23, 30 and 100 days of age, in order to study the short- and long-term effects of the treatment with hCG on the development of the testes and sex accessory organs. Rats treated with hCG on days 2-4 showed increased number and size of foetal Leydig cells at 5 days of age. However, long-term effects include decreased numbers of adult-type Leydig cells, decreased weight of the testes and sex accessory organs, decreased basal and hCG-stimulated testosterone secretion, and delayed balano-preputial separation. In contrast, animals treated with hCG on days 20-22 showed similar short- and long-term effects, consisting of increased number of adult-type Leydig cells and macrophages, increased weight of the testes and sex accessory organs and advanced balano-preputial separation. In adulthood, both groups showed normal reproductive function. These results seem to indicate that the effects of hCG treatment in prepubertal rats are dependent on the type of Leydig cell stimulated, and suggest that foetal Leydig cells play a regulatory role in the early postnatal testicular development.
引用
收藏
页码:527 / 534
页数:8
相关论文
共 50 条
  • [21] UBIQUITOUS HUMAN CHORIONIC-GONADOTROPIN
    不详
    LANCET, 1977, 2 (8048): : 1116 - 1117
  • [22] DEPYROGENATION OF HUMAN CHORIONIC-GONADOTROPIN
    JOHNSON, DS
    LIN, K
    FITZGERALD, E
    LEPAGE, B
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1979, (SEP): : 106 - 106
  • [23] HUMAN CHORIONIC-GONADOTROPIN IN CRANIOPHARYNGIOMA
    HARRIS, P
    PERRY, L
    COATES, PJ
    DONIACH, I
    LOWE, DG
    AFSHAR, F
    CHARD, T
    WASS, J
    BESSER, GM
    JOURNAL OF PATHOLOGY, 1988, 154 (01): : A102 - A102
  • [24] PHOSPHORYLATION OF HUMAN CHORIONIC-GONADOTROPIN
    KEUTMANN, HT
    RATANABANANGKOON, K
    PIERCE, MW
    RYAN, RJ
    FEDERATION PROCEEDINGS, 1982, 41 (04) : 1460 - 1460
  • [25] IMMUNOCHEMISTRY OF HUMAN CHORIONIC-GONADOTROPIN
    CANFIELD, RE
    BIRKEN, S
    EHRLICH, P
    ARMSTRONG, G
    ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY, 1984, 176 : 199 - 215
  • [26] IMMUNOCHEMISTRY OF HUMAN CHORIONIC-GONADOTROPIN
    ARMSTRONG, EG
    BIRKEN, S
    MOYLE, WR
    CANFIELD, RE
    BIOCHEMICAL ACTIONS OF HORMONES, 1986, 13 : 91 - 128
  • [27] SUPPRESSION BY HUMAN CHORIONIC-GONADOTROPIN
    ADCOCK, EW
    SCIENCE, 1974, 184 (4139) : 914 - 914
  • [28] MEASUREMENT OF HUMAN CHORIONIC-GONADOTROPIN
    KOSASA, TS
    JOURNAL OF REPRODUCTIVE MEDICINE, 1981, 26 (04) : 201 - 206
  • [29] ALCOHOLISM AND HUMAN CHORIONIC-GONADOTROPIN
    BRADLEY, P
    MEDICAL JOURNAL OF AUSTRALIA, 1978, 1 (06) : 337 - 338
  • [30] IMMUNOCYTOCHEMISTRY OF HUMAN CHORIONIC-GONADOTROPIN IN HUMAN CHORIONIC VILLI
    HAMASAKI, K
    OKAMURA, Y
    UEDA, H
    KAGAWA, H
    FUJIMOTO, S
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1987, 156 (02) : 479 - 483